Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes
暂无分享,去创建一个
H. Goldschmidt | D. Siegel | P. Hari | R. Hájek | P. Moreau | H. Ludwig | S. Knop | M. Mateos | R. Abonour | W. Bensinger | K. Iskander | S. Feng | S. Aggarwal | M. Obreja | K. Song